Top

Digestive Diseases and Sciences

Published in:

01-10-2011 | Original Article

Disease-Specific Knowledge, Coping, and Adherence in Patients with Inflammatory Bowel Disease

Authors: Anilga Moradkhani, Lauren Kerwin, Sharon Dudley-Brown, James H. Tabibian

Published in: Digestive Diseases and Sciences | Issue 10/2011

Abstract

Background

Little is known about the effects of disease-related education and knowledge in individuals with inflammatory bowel disease (IBD). The limited available research on this topic suggests there may be potential benefits to disease-related patient education. We hypothesized that individuals with greater IBD knowledge would have more coping strategies and higher medication adherence.

Methods

A total of 111 adults with IBD residing in the United States were recruited online by convenience sampling from IBD support group forums. IBD knowledge, coping, and medication adherence were assessed using standardized questionnaires. Data on seventeen clinico-demographic variables were also collected. A Pearson correlation was conducted to examine the relationship between IBD knowledge and use of coping strategies and also between IBD knowledge and medication adherence. Multivariate regression and one-way ANOVA tests were used to assess the continuous and categorical clinico-demographic variables, respectively, for potential confounding.

Results

A significant positive association was found between greater IBD knowledge and active coping scores (r = 0.189, P = 0.024), instrumental support scores (r = 0.160, P = 0.047), planning scores (r = 0.159, P = 0.048), and emotional support scores (r = 0.159, P = 0.048). A relationship between knowledge and adherence score was not found. Significant relationships were found between four clinico-demographic variables and coping.

Conclusion

Greater IBD knowledge appears to be associated with the use of more adaptive coping strategies in patients with IBD, suggesting that providing disease-related patient education may enhance coping in this population. Future studies should explore the utility of formal disease-related patient education in improving these and other outcomes.

Dudley-Brown S. Prevention of psychological distress in persons with inflammatory bowel disease. Issues Ment Health Nurs. 2002;23:403–422.PubMedCrossRef

Crohn’s and Colitis Foundation of America. Retrieved from: http://www.ccfa.org/; 2009. Cited October 13, 2009.

Drossman DA, Patrick DL, Mitchell CM, Zagami EA, Appelbaum MI. Health-related quality of life in inflammatory bowel disease. Functional status and patient worries and concerns. Dig Dis Sci. 1989;34:1379–1386.PubMedCrossRef

Drossman DA, Leserman J, Li ZM, Mitchell CM, Zagami EA, Patrick DL. The rating form of IBD patient concerns: A new measure of health status. Dig Dis Sci. 1991;36:1746–1755.PubMedCrossRef

Dudley-Brown S, Nag A, Cullinan C, Ayers M, Hass S, Panjabi S. Health-related quality-of-life evaluation of Crohn disease patients after receiving natalizumab therapy. Gastroenterol Nurs. 2009;32:327–339.PubMedCrossRef

Larsson K, Lööf L, Rönnblom A, Nordin K. Quality of life for patients with exacerbation in inflammatory bowel disease and how they cope with disease activity. J Psychosom Res. 2008;64:139–148.PubMedCrossRef

Lix LM, Graff LA, Walker JR, et al. Longitudinal study of quality of life and psychological functioning for active, fluctuating, and inactive disease patterns in inflammatory bowel disease. Inflamm Bowel Dis. 2008;14:1575–1584.PubMedCrossRef

Hawthorne AB, Rubin G, Ghosh S. Review article: medication non-adherence in ulcerative colitis-strategies to improve adherence with mesalazine and other maintenance therapies. Aliment Pharmacol Ther. 2008;27:1157–1166.PubMedCrossRef

Sood A, Midha V, Sood N, Kaushal V. Self-reported disease awareness—A questionnaire survey of ulcerative colitis patients. Indian J Gastroenterol. 2001;20:6–8.PubMed

10.

Cervený P, Bortlík M, Kubena A, Vlcek J, Lakatos PL, Lukás M. Nonadherence in inflammatory bowel disease: Results of factor analysis. Inflamm Bowel Dis. 2007;13:1244–1249.PubMedCrossRef

11.

Jones SC, Gallacher B, Lobo AJ, Axon AT. A patient knowledge questionnaire in inflammatory bowel disease. J Clin Gastroenterol. 1993;17:21–24.PubMedCrossRef

12.

Sewitch MJ, Abrahamowicz M, Barkun A, Bitton A, et al. Patient nonadherence to medication in inflammatory bowel disease. Am J Gastroenterol. 2003;98:1535–1544.PubMedCrossRef

13.

Mazzuca SA. Does patient education in chronic disease have therapeutic value? J Chronic Dis. 1982;35:521–529.PubMedCrossRef

14.

Quan H, Present JW, Sutherland LR. Evaluation of educational programs in inflammatory bowel disease. Inflamm Bowel Dis. 2003;9:356–362.PubMedCrossRef

15.

Scholmerich J, Sedlak P, Hoppe-Seyler P, Gerok W. The information needs and fears of patients with inflammatory bowel disease. Hepatogastroenterology. 1987;34:182–185.PubMed

16.

Casati J, Toner BB, De Rooy EC, Drossman DA, Maunder RG. Concerns of patients with inflammatory bowel disease: A review of emerging themes. Dig Dis Sci. 2000;45:26–31.PubMedCrossRef

17.

Cima RR, Anderson KJ, Larson DW, et al. Internet use by patients in an inflammatory bowel disease specialty clinic. Inflamm Bowel Dis. 2007;13:1266–1270.PubMedCrossRef

18.

Oxelmark L, Magnusson A, Löfberg R, Hillerås P. Group-based intervention program in inflammatory bowel disease patients: Effects on quality of life. Inflamm Bowel Dis. 2007;13:182–190.PubMedCrossRef

19.

Kennedy A, Robinson A, Hann M, Thompson D, Wilkin D. A cluster-randomised controlled trial of a patient-centered guidebook for patients with ulcerative colitis: Effect on knowledge, anxiety and quality of life. Health Soc Care Commun. 2003;11:64–72.CrossRef

20.

Dorrian A, Dempster M, Adair P. Adjustment to inflammatory bowel disease: The relative influence of illness perceptions and coping. Inflamm Bowel Dis. 2009;15:47–55.PubMedCrossRef

21.

Moser G, Tillinger W, Sachs G, et al. Disease-related worries and concerns: A study on out-patients with inflammatory bowel disease. Eur J Gastroenterol Hepatol. 1995;7:853–858.PubMed

22.

Probert CS, Mayberry JF. Inflammatory bowel disease: Patients’ expectations in the 1990s. J R Soc Med. 1991;84:131–132.PubMed

23.

Waters BM, Jensen L, Fedorak RN. Effects of formal education for patients with inflammatory bowel disease: A randomized controlled trial. Can J Gastroenterol. 2005;19:235–244.PubMed

24.

Eaden JA, Abrams K, Mayberry JF. The Crohn’s and Colitis knowledge score: A test for measuring patient knowledge in inflammatory bowel disease. Am J Gastroenterol. 1999;94:3560–3566.PubMedCrossRef

25.

Carver CS. You want to measure coping but your protocol’s too long: Consider the brief COPE. Int J Behav Med. 1997;4:92–100.PubMedCrossRef

26.

Carver CS, Scheier MF, Weintraub JK. Assessing coping strategies: A theoretically based approach. J Pers Soc Psychol. 1989;56:267–283.PubMedCrossRef

27.

Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence and long-term predictive validity of blood pressure control. Med Care. 1986;24:67–74.PubMedCrossRef

28.

Martin A, Leone L, Castagliuolo I, Di Mario F, Naccarato R. What do patients want to know about their inflammatory bowel disease? Ital J Gastroenterol. 1992;24:477–480.PubMed

29.

Finlay DG, Basu D, Sellin JH. Effect of race and ethnicity on perceptions of inflammatory bowel disease. Inflamm Bowel Dis. 2006;12:503–507.PubMedCrossRef

Title: Disease-Specific Knowledge, Coping, and Adherence in Patients with Inflammatory Bowel Disease
Authors: Anilga Moradkhani
Lauren Kerwin
Sharon Dudley-Brown
James H. Tabibian
Publication date: 01-10-2011
Publisher: Springer US
Published in: Digestive Diseases and Sciences / Issue 10/2011
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI: https://doi.org/10.1007/s10620-011-1714-y

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 10/2011

Efficacy and Tolerability of Split-Dose PEG Compared with Split-Dose Aqueous Sodium Phosphate for Outpatient Colonoscopy: A Randomized, Controlled Trial

Lifestyle Change Influences on GERD in Japan: A Study of Participants in a Health Examination Program

Algorithmic Approach to Patients Presenting with Heartburn and Epigastric Pain Refractory to Empiric Proton Pump Inhibitor Therapy

NaOH-Induced Crohn’s Colitis in Rats: A Novel Experimental Model

Effectiveness of Endoclips for the Treatment of Stigmata of Recent Hemorrhage in the Colon of Patients with Acute Lower Gastrointestinal Tract Bleeding

Tracheal Aspiration of Capsule Endoscopes: Completing a Cases Compilation

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials